{
    "xml": "<topic id=\"PHP1636\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/fluvastatin\" basename=\"fluvastatin\" title=\"FLUVASTATIN\">\n<title>FLUVASTATIN</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_603\" namespace=\"/interactions/list-of-drug-interactions/lipid-regulating-drugs/statins/fluvastatin\">Fluvastatin</xref>\n</p>\n<data name=\"vtmid\">96307003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_957233137\" title=\"Statins\">Statins</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34581\" title=\"STATINS\" namespace=\"/drug-classes/statins\">STATINS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP71606\" outputclass=\"indicationsAndDose\" rev=\"1.25\" parent=\"/drugs/fluvastatin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunct to diet in primary hypercholesterolaemia or combined (mixed) hyperlipidaemia (types IIa and IIb)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using immediate-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 20&#8211;40&#8239;mg daily, dose to be taken in the evening, increased if necessary up to 80&#8239;mg daily in 2 divided doses, dose to be adjusted at intervals of at least 4 weeks.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By mouth using modified-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>80&#8239;mg daily, dose form is not appropriate for initial dose titration.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of coronary events after percutaneous coronary intervention</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using immediate-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>80&#8239;mg daily.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By mouth using modified-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>80&#8239;mg daily, dose form is not appropriate for initial dose titration.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71584\" outputclass=\"sideEffects\" rev=\"1.6\" parent=\"/drugs/fluvastatin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Vasculitis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71655\" outputclass=\"breastFeeding\" parent=\"/drugs/fluvastatin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71591\" outputclass=\"renalImpairment\" parent=\"/drugs/fluvastatin\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Manufacturer advises doses above 40&#8239;mg daily should be initiated with caution if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71595\" outputclass=\"patientAndCarerAdvice\" rev=\"1.15\" parent=\"/drugs/fluvastatin\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patient counselling is advised for fluvastatin tablets/capsules (muscle effects).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71551\" outputclass=\"nationalFunding\" rev=\"1.5\" parent=\"/drugs/fluvastatin\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (February 2004) that fluvastatin is accepted for restricted use for the secondary prevention of coronary events after percutaneous coronary angioplasty; if the patient has previously been receiving another statin, then there is no need to change the statin.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1636-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/fluvastatin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76760\" title=\"Modified-release tablet\" namespace=\"/drugs/fluvastatin/modified-release-tablet\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76771\" title=\"Capsule\" namespace=\"/drugs/fluvastatin/capsule\">Capsule</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP98616\" namespace=\"/guidance/prescribing-in-breast-feeding\" title=\"Prescribing in breast-feeding\" count=\"1\" rel=\"backlink\">Prescribing in breast-feeding</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_603\" namespace=\"/interactions/list-of-drug-interactions/lipid-regulating-drugs/statins/fluvastatin\" title=\"Fluvastatin\" count=\"1\" rel=\"link\">Fluvastatin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34581\" namespace=\"/drug-classes/statins\" title=\"STATINS\" count=\"1\" rel=\"link\">STATINS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76760\" namespace=\"/drugs/fluvastatin/modified-release-tablet\" title=\"Modified-release tablet\" count=\"1\" rel=\"link\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76771\" namespace=\"/drugs/fluvastatin/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n</links>\n</topic>",
    "id": "PHP1636",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/fluvastatin",
    "basename": "fluvastatin",
    "title": "FLUVASTATIN",
    "interactants": [
        {
            "id": "bnf_int_603",
            "label": "Fluvastatin"
        }
    ],
    "vtmid": "96307003",
    "drugClassification": [
        "Statins"
    ],
    "inheritsFromClass": [
        "STATINS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Adjunct to diet in primary hypercholesterolaemia or combined (mixed) hyperlipidaemia (types IIa and IIb)",
                        "html": "Adjunct to diet in primary hypercholesterolaemia or combined (mixed) hyperlipidaemia (types IIa and IIb)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using modified-release medicines"
                    ],
                    "textContent": "By mouth using modified-release medicines",
                    "html": "By mouth using modified-release medicines"
                },
                "adult": [
                    {
                        "textContent": "Initially 20&#8211;40 mg daily, dose to be taken in the evening, increased if necessary up to 80 mg daily in 2 divided doses, dose to be adjusted at intervals of at least 4 weeks.",
                        "html": "<p>Initially 20&#8211;40&#8239;mg daily, dose to be taken in the evening, increased if necessary up to 80&#8239;mg daily in 2 divided doses, dose to be adjusted at intervals of at least 4 weeks.</p>"
                    },
                    {
                        "textContent": "80 mg daily, dose form is not appropriate for initial dose titration.",
                        "html": "<p>80&#8239;mg daily, dose form is not appropriate for initial dose titration.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of coronary events after percutaneous coronary intervention",
                        "html": "Prevention of coronary events after percutaneous coronary intervention"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using modified-release medicines"
                    ],
                    "textContent": "By mouth using modified-release medicines",
                    "html": "By mouth using modified-release medicines"
                },
                "adult": [
                    {
                        "textContent": "80 mg daily.",
                        "html": "<p>80&#8239;mg daily.</p>"
                    },
                    {
                        "textContent": "80 mg daily, dose form is not appropriate for initial dose titration.",
                        "html": "<p>80&#8239;mg daily, dose form is not appropriate for initial dose titration.</p>"
                    }
                ]
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Vasculitis",
                        "html": "Vasculitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ]
            }
        }
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Manufacturer advises doses above 40 mg daily should be initiated with caution if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Manufacturer advises doses above 40&#8239;mg daily should be initiated with caution if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patient counselling is advised for fluvastatin tablets/capsules (muscle effects).",
                "html": "<p>Patient counselling is advised for fluvastatin tablets/capsules (muscle effects).</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (February 2004) that fluvastatin is accepted for restricted use for the secondary prevention of coronary events after percutaneous coronary angioplasty; if the patient has previously been receiving another statin, then there is no need to change the statin.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (February 2004) that fluvastatin is accepted for restricted use for the secondary prevention of coronary events after percutaneous coronary angioplasty; if the patient has previously been receiving another statin, then there is no need to change the statin.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76760",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76771",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP98616",
                "label": "Prescribing in breast-feeding",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_603",
                "label": "Fluvastatin",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34581",
                "label": "STATINS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76760",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76771",
                "label": "Capsule",
                "type": "medicinalForm"
            }
        ]
    }
}